Article · 2017
Editor
Alexander E Berezin
Department of Internal Medicine, Zaporozhye State Medical University, Ukraine
About
As published by the journal they serve.
Dr. Alexander E. Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as a Professor of Medicine in the State Medical University of Zaporozhye (Ukraine). As a Chief of Cardiology Unit of Internal Medicine Department, his research goals are fundamental study of biological markers, the implementation of visualization procedures and percutaneous cardiovascular interventions, the development of cardiovascular prevention and rehabilitation, especially in the field affected heart failure, atherosclerosis, and coronary artery disease. Based on this research and training in heart failure he has received several awards and honors, such as: Award of The Cabinet of Ministers of Ukraine (2002), Honor of The Ukrainian Cardiology Association (2004), and is serving one of the active members of the European Cardiology Society. He has authored more 550 research articles, 15 books/chapters
Research interests
Journals they serve
The seats these journals name them in.
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2017
Endothelial Progenitor Cell Number to Apoptotic Endothelial Cell-Derived Micro Particles Ratio in Chronic Heart Failure Phenotypes
Article · 2017
Number of Circulating Apoptotic Endothelial Cell-Derived Micro Particles as a Predictor of Metabolically Unhealthy Obesity
Article · 2016
The Promises, Methodological Discrepancies and Pitfalls in Measurement of Cell-Derived Extracellular Vesicles in Diseases
Article · 2016
Are Endothelial Cell-Derived Microparticles Predictive Biomarkers inCardiovascular Diseases?
Article · 2015
Apoptotic-derived micro particles to endothelial-derived progenitor cells ratio as a novel biomarker in advanced heart failure patients
Article · 2015
Apoptotic-derived microparticles to endothelial-derived progenitor cells ratio as a novel biomarker in advanced heart failure patients
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
